Capsigen Patents

Patent portfolio assigned to Capsigen (verified via public assignee records). AAV capsid-engineering biotech (TRADE platform; ties to Oregon Health & Science University). Biogen is a confirmed named partner via a collaboration (up to ~$1.3B in milestones) to develop novel AAV capsids for CNS/neuromuscular disorders. has_patents=true: patent application AU2024266671A1 'Capsids and methods of targeting neurons' lists Capsigen Inc as applicant (per Google Patents search result; direct page fetch was blocked). Capsida Biotherapeutics noted as a comparable capsid-engineering peer. Count not reliably enumerable.